Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China
· Delayed Price · Currency is CNY 49.92
+0.96 (1.96%)
At close: Mar 28, 2025, 2:57 PM CST
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 22.14 billion as of April 2, 2025. Its market cap has increased by 40.57% in one year.
Market Cap
22.14B
Enterprise Value
22.25B
Revenue
360.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
49.92
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 22.14B, an increase of 34.69%. That is a compound annual growth rate of 9.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 21.67B | 25.73% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 329.37B |
| Shenzhen Mindray Bio-Medical Electronics | 286.21B |
| WuXi AppTec | 195.66B |
| Aier Eye Hospital Group | 124.02B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.08B |
| Shanghai United Imaging Healthcare | 104.15B |
| Yunnan Baiyao Group Co.,Ltd | 101.83B |
| Sichuan Biokin Pharmaceutical | 99.65B |